Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. TX BioHistory (TM)
Career
Job Search Post a Job Destination TX
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
Patient
 Clinical Trials
 Drug Development
 Resources
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
 
Community Service Ad: American Red Cross, Together, we can save a life
Want to target global biotech trade media?  Use B3C newswire  services.
 
Facilities
 
Want global media exposure for your company? Visit B3C to learn how.

Videoconferencing

The New Drug Development Process.

The Food and Drug Administration's Center for Drug Evaluation and Research has installed state-of-the-art videoconferencing technology for communicating with employees inside the organization as well as with industry representatives, consumers, healthcare professionals, academia, and other government agencies.

CDER's videoconferencing enhances face-to-face meetings by allowing participants the opportunity to listen, watch and participate "live" in a normal two-way conversation.


Videoconferencing can be used for such diverse purposes as:

  • delivering a speech to an overseas audience from CDER facilities;
  • "attending" a committee meeting being held in another city;
  • interviewing prospective new employees;
  • "attending" a training session being held in another city;
  • holding a product review meeting with a division located in another CDER building.

CDER currently has videoconferencing capabilities in the Parklawn building, Woodmont Office Complex II, and Corporate Boulevard building.

For more information on the Center's videoconferencing capabilities or to schedule an event, telephone CDER's Office of Training and Communications at (301) 827-1243.

Source: U.S. Food and Drug Administration Center for Drug Evaluation and Research Handbook.


Back to The New Drug Development Process

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2012 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advertising

TexasLifeScience.com is owned and published by Info.Resource, Inc.